Trevi Therapeutics Inc (TRVI)

EBITDA

-$51.04M

TTM · Period ending: · USD

TRVI logo

TRVI EBITDA

Latest reported-$51.04M
TRVI EBITDA (-$8.62M → -$51.04M)
High-resolution chart · PNG

TRVI ebitda history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Trevi Therapeutics Inc EBITDA — Annual fiscal periods (USD)
Period endingEBITDA (USD)
-42,679,000
-47,790,000
-28,583,000
-27,982,000
-32,709,000
-32,272,999
-26,606,000
-18,385,000
-8,188,000
-8,621,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.